Skip to content
10-K

Annual Report

Humacyte, Inc. HUMA HUMAW

0001818382-26-000004

← back to feed
Filed
Mar 27, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 24, 2026 222.02M sh
Shares Diluted FY 2025 · Dec 31, 2025 158.16M sh
Shares Diluted FY 2025 · Dec 31, 2024 118.48M sh
Capex FY 2025 · Dec 31, 2025 $884K
Capex FY 2025 · Dec 31, 2024 $1.57M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$105.04M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$98.12M
Long Term Debt FY 2025 · Dec 31, 2025 $35.44M
Long Term Debt FY 2025 · Dec 31, 2024 $0
Cash And Equivalents FY 2025 · Dec 31, 2025 $50.5M
Cash And Equivalents FY 2025 · Dec 31, 2024 $44.94M
Stockholders Equity FY 2025 · Dec 31, 2025 $3.11M
Stockholders Equity FY 2025 · Dec 31, 2024 −$52.67M
Stockholders Equity FY 2025 · Dec 31, 2023 $13.55M
Current Liabilities FY 2025 · Dec 31, 2025 $18.37M
Current Liabilities FY 2025 · Dec 31, 2024 $19.95M
Total Liabilities FY 2025 · Dec 31, 2025 $113.26M
Total Liabilities FY 2025 · Dec 31, 2024 $190.54M
Current Assets FY 2025 · Dec 31, 2025 $67.8M
Current Assets FY 2025 · Dec 31, 2024 $47.86M
Total Assets FY 2025 · Dec 31, 2025 $116.37M
Total Assets FY 2025 · Dec 31, 2024 $137.87M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.26
Eps Diluted FY 2025 · Dec 31, 2024 −$1.26
Eps Basic FY 2025 · Dec 31, 2025 −$0.26
Eps Basic FY 2025 · Dec 31, 2024 −$1.26
Rd Expense FY 2025 · Dec 31, 2025 $69.3M
Rd Expense FY 2025 · Dec 31, 2024 $88.6M
Net Income FY 2025 · Dec 31, 2025 −$40.83M
Net Income FY 2025 · Dec 31, 2024 −$148.7M
Operating Income FY 2025 · Dec 31, 2025 −$108.14M
Operating Income FY 2025 · Dec 31, 2024 −$114.4M
Cost Of Revenue FY 2025 · Dec 31, 2025 $9.7M
Cost Of Revenue FY 2025 · Dec 31, 2024 $0
Revenue FY 2025 · Dec 31, 2025 $2.04M
Revenue FY 2025 · Dec 31, 2024 $0